Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis

Authors: Song-Tay Lee, Min-Hua Lu, Lan-Hsiang Chien, Ting-Feng Wu, Li-Chien Huang, Gwo-Ing Liao

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Pomegranate possesses many medicinal properties such as antioxidant, anti-inflammation and antitumor. It has been extensively used as a folk medicine by many cultures. Pomegranate fruit has been shown to have the inhibitory efficacy against prostate cancer and lung cancer in vitro and in vivo. It can be exploited in chemoprevention and chemotherapy of prostate cancer. In this study we examined the anti-cancer efficacy of pomegranate fruit grown in Taiwan against urinary bladder urothelial carcinoma (UBUC) and its mechanism of action.

Methods

Edible portion of Taiwanese pomegranate was extracted using ethanol and the anti-cancer effectiveness of ethanol extract was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Flow cytometry and western immunoblotting were exploited to uncover the molecular pathways underlying anti-UBUC activity of Taiwanese pomegranate ethanol extract.

Results

This study demonstrated that Taiwanese pomegranate fruit ethanol extract (PEE) could effectively restrict the proliferation of UBUC T24 and J82 cells. Cell cycle analyses indicated that the S phase arrest induced by PEE treatment might be caused by an increase in cyclin A protein level and a decrease in the expression of cyclin-dependent kinase 1. The results of western immunoblotting demonstrated that PEE treatment could not only evoke the activation of pro-caspase-3, -8,-9 but also increase Bax/Bcl-2 ratio in T24 cells. The above observations implicated that PEE administration might trigger the apoptosis in T24 cells through death receptor signaling and mitochondrial damage pathway. Besides we found that PEE exposure to T24 cells could provoke intensive activation of procaspase-12 and enhance the expressions of CHOP and Bip, endoplasmic reticulum (ER) stress marker, suggesting that ER stress might be the cardinal apoptotic mechanism of PEE-induced inhibition of bladder cancer cell.

Conclusions

The analytical results of this study help to provide insight into the molecular mechanism of induced bladder cancer cell apoptosis by pomegranate and to develop novel mechanism-based chemopreventive strategy for bladder cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Block G, Patterson B, Subar A: Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Canc. 1992, 18: 1-29. 10.1080/01635589209514201.CrossRef Block G, Patterson B, Subar A: Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Canc. 1992, 18: 1-29. 10.1080/01635589209514201.CrossRef
2.
go back to reference Mukhtar H, Ahmad N: Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol. 1999, 158: 207-210. 10.1006/taap.1999.8721.CrossRefPubMed Mukhtar H, Ahmad N: Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol. 1999, 158: 207-210. 10.1006/taap.1999.8721.CrossRefPubMed
3.
go back to reference Parnes HL, Thompson IM, Ford LG: Prevention of hormone-related cancers: prostate cancer. J Clin Oncol. 2005, 23: 368-377. 10.1200/JCO.2005.08.027.CrossRefPubMed Parnes HL, Thompson IM, Ford LG: Prevention of hormone-related cancers: prostate cancer. J Clin Oncol. 2005, 23: 368-377. 10.1200/JCO.2005.08.027.CrossRefPubMed
4.
go back to reference Saleem M, Adhami VM, Siddiqui IA, Mukhtar H: Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Canc. 2003, 47: 13-23. 10.1207/s15327914nc4701_2.CrossRef Saleem M, Adhami VM, Siddiqui IA, Mukhtar H: Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Canc. 2003, 47: 13-23. 10.1207/s15327914nc4701_2.CrossRef
5.
go back to reference Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Canc. 2003, 3: 768-780. 10.1038/nrc1189.CrossRef Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Canc. 2003, 3: 768-780. 10.1038/nrc1189.CrossRef
7.
go back to reference Cerda B, Ceron JJ, Tomas-Barberan FA, Espin JC: Repeated oral administration of high doses of pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agri Food Chem. 2003, 51: 3493-3501. 10.1021/jf020842c.CrossRef Cerda B, Ceron JJ, Tomas-Barberan FA, Espin JC: Repeated oral administration of high doses of pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agri Food Chem. 2003, 51: 3493-3501. 10.1021/jf020842c.CrossRef
8.
go back to reference Cerda B, Llorach R, Ceron JJ, Espin JC, Tomas-Barberan FA: Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr. 2003, 42: 18-28. 10.1007/s00394-003-0396-4.CrossRefPubMed Cerda B, Llorach R, Ceron JJ, Espin JC, Tomas-Barberan FA: Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr. 2003, 42: 18-28. 10.1007/s00394-003-0396-4.CrossRefPubMed
9.
go back to reference Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA: Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agri Food Chem. 2000, 48: 4581-4589. 10.1021/jf000404a.CrossRef Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA: Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agri Food Chem. 2000, 48: 4581-4589. 10.1021/jf000404a.CrossRef
10.
go back to reference Hong MY, Seeram NP, Heber D: Pomegranate polyphenols downregulate expression of androgen synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem. 2008, 19: 848-855. 10.1016/j.jnutbio.2007.11.006.CrossRefPubMedPubMedCentral Hong MY, Seeram NP, Heber D: Pomegranate polyphenols downregulate expression of androgen synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem. 2008, 19: 848-855. 10.1016/j.jnutbio.2007.11.006.CrossRefPubMedPubMedCentral
11.
go back to reference Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H: Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis. 2007, 28: 163-173. 10.1093/carcin/bgl145.CrossRefPubMed Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H: Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis. 2007, 28: 163-173. 10.1093/carcin/bgl145.CrossRefPubMed
12.
go back to reference Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H: Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Canc Res. 2007, 67: 3475-3482. 10.1158/0008-5472.CAN-06-3941.CrossRef Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H: Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Canc Res. 2007, 67: 3475-3482. 10.1158/0008-5472.CAN-06-3941.CrossRef
13.
go back to reference Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H: Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A. 2005, 102: 14813-14818. 10.1073/pnas.0505870102.CrossRefPubMedPubMedCentral Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H: Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A. 2005, 102: 14813-14818. 10.1073/pnas.0505870102.CrossRefPubMedPubMedCentral
14.
go back to reference Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A: Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Canc Ther. 2008, 7: 2662-2671. 10.1158/1535-7163.MCT-08-0136.CrossRef Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A: Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Canc Ther. 2008, 7: 2662-2671. 10.1158/1535-7163.MCT-08-0136.CrossRef
15.
go back to reference Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D: Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008, 32: 475-480.PubMed Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D: Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008, 32: 475-480.PubMed
16.
go back to reference Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A: Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Canc Res. 2006, 12: 4018-4026. 10.1158/1078-0432.CCR-05-2290.CrossRef Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A: Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Canc Res. 2006, 12: 4018-4026. 10.1158/1078-0432.CCR-05-2290.CrossRef
17.
go back to reference Bane BL, Rao JY, Hemstreet GP: Pathology and staging of bladder cancer. Semin Oncol. 1996, 23: 546-570.PubMed Bane BL, Rao JY, Hemstreet GP: Pathology and staging of bladder cancer. Semin Oncol. 1996, 23: 546-570.PubMed
18.
go back to reference Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998, 160: 645-659. 10.1016/S0022-5347(01)62747-2.CrossRefPubMed Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998, 160: 645-659. 10.1016/S0022-5347(01)62747-2.CrossRefPubMed
19.
go back to reference Zieger K, Wolf H, Olsen PR, Hojgaard K: Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int. 2000, 85: 824-828.CrossRefPubMed Zieger K, Wolf H, Olsen PR, Hojgaard K: Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int. 2000, 85: 824-828.CrossRefPubMed
20.
go back to reference Chen SH, Wang YW, Hsu JL, Chang HY, Wang CY, Shen PT, Chiang CW, Chuang JJ, Tsai HW, Gu PW, Chang FC, Liu HS, Chow NH: Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol. 2010, 242: 26-35.CrossRef Chen SH, Wang YW, Hsu JL, Chang HY, Wang CY, Shen PT, Chiang CW, Chuang JJ, Tsai HW, Gu PW, Chang FC, Liu HS, Chow NH: Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol. 2010, 242: 26-35.CrossRef
21.
go back to reference Bendris N, Lemmers B, Blanchard JM, Arsic N: Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements. PLoS ONE. 2011, 6: e22879-10.1371/journal.pone.0022879.CrossRefPubMedPubMedCentral Bendris N, Lemmers B, Blanchard JM, Arsic N: Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements. PLoS ONE. 2011, 6: e22879-10.1371/journal.pone.0022879.CrossRefPubMedPubMedCentral
22.
go back to reference Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 2002, 59: 1317-1326. 10.1007/s00018-002-8510-y.CrossRefPubMed Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 2002, 59: 1317-1326. 10.1007/s00018-002-8510-y.CrossRefPubMed
23.
go back to reference Braun RJ, Zischka H: Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim Biophys Acta. 2008, 1783: 1418-1435. 10.1016/j.bbamcr.2008.01.015.CrossRefPubMed Braun RJ, Zischka H: Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim Biophys Acta. 2008, 1783: 1418-1435. 10.1016/j.bbamcr.2008.01.015.CrossRefPubMed
24.
go back to reference Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC: Arsenic methylation and bladder cancer risk in Taiwan. Canc Causes Contr. 2003, 14: 303-310. 10.1023/A:1023905900171.CrossRef Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC: Arsenic methylation and bladder cancer risk in Taiwan. Canc Causes Contr. 2003, 14: 303-310. 10.1023/A:1023905900171.CrossRef
25.
go back to reference Shi C, Yu L, Yang F, Yan J, Zeng H: A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun. 2003, 2003 (309): 578-583.CrossRef Shi C, Yu L, Yang F, Yan J, Zeng H: A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun. 2003, 2003 (309): 578-583.CrossRef
Metadata
Title
Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis
Authors
Song-Tay Lee
Min-Hua Lu
Lan-Hsiang Chien
Ting-Feng Wu
Li-Chien Huang
Gwo-Ing Liao
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-364

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue